BioSenic S.A. (0R55.L)

EUR 0.01

(-14.29%)

Total Debt Summary of BioSenic S.A.

BioSenic S.A.'s latest annual total debt in 2023 was 28.16 Million EUR , up 35.17% from previous year.
BioSenic S.A.'s latest quarterly total debt in 2024 Q2 was 25.68 Million EUR , up 4.33% from previous quarter.
BioSenic S.A. reported annual total debt of 20.83 Million EUR in 2022, up 0.17% from previous year.
BioSenic S.A. reported annual total debt of 20.79 Million EUR in 2021, up 40.56% from previous year.
BioSenic S.A. reported quarterly total debt of 25.68 Million EUR for 2024 Q1, down -8.8% from previous quarter.
BioSenic S.A. reported quarterly total debt of 28.16 Million EUR for 2023 Q3, up 12.49% from previous quarter.

Annual Total Debt Chart of BioSenic S.A. (2023 - 2011)

Historical Annual Total Debt of BioSenic S.A. (2023 - 2011)

Year	Total Debt	Total Debt Growth
2023	28.16 Million EUR	35.17%
2022	20.83 Million EUR	0.17%
2021	20.79 Million EUR	40.56%
2020	14.79 Million EUR	7.9%
2019	13.71 Million EUR	6.71%
2018	12.85 Million EUR	8.9%
2017	11.8 Million EUR	-4.89%
2016	12.4 Million EUR	-0.19%
2015	12.43 Million EUR	-34.37%
2014	18.94 Million EUR	240.64%
2013	5.56 Million EUR	29.12%
2012	4.3 Million EUR	32.85%
2011	3.24 Million EUR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	25.68 Million EUR	4.33%
2024 Q1	25.68 Million EUR	-8.8%
2023 Q3	28.16 Million EUR	12.49%
2023 Q4	28.16 Million EUR	0.0%
2023 Q1	24.74 Million EUR	18.76%
2023 Q2	25.03 Million EUR	1.18%
2023 FY	28.16 Million EUR	35.17%
2022 Q3	23.79 Million EUR	19.54%
2022 FY	20.83 Million EUR	0.17%
2022 Q4	20.83 Million EUR	-12.43%
2022 Q2	19.9 Million EUR	0.0%
2021 Q2	12.54 Million EUR	0.0%
2021 Q4	20.79 Million EUR	0.0%
2021 FY	20.79 Million EUR	40.56%
2020 Q2	21.93 Million EUR	0.0%
2020 FY	14.79 Million EUR	7.9%
2020 Q4	14.79 Million EUR	0.0%
2019 FY	13.71 Million EUR	6.71%
2019 Q2	16 Million EUR	0.0%
2019 Q4	13.71 Million EUR	0.0%
2018 FY	12.85 Million EUR	8.9%
2018 Q4	12.85 Million EUR	0.0%
2018 Q2	13.35 Million EUR	0.0%
2017 FY	11.8 Million EUR	-4.89%
2017 Q4	11.8 Million EUR	0.0%
2017 Q2	11.74 Million EUR	0.0%
2016 Q4	12.4 Million EUR	0.0%
2016 Q2	12.89 Million EUR	0.0%
2016 FY	12.4 Million EUR	-0.19%
2015 Q2	9.51 Million EUR	0.0%
2015 FY	12.43 Million EUR	-34.37%
2015 Q4	12.43 Million EUR	0.0%
2014 FY	18.94 Million EUR	240.64%
2014 Q4	18.94 Million EUR	124.92%
2014 Q3	8.42 Million EUR	0.0%
2013 Q4	5.56 Million EUR	0.0%
2013 FY	5.56 Million EUR	29.12%
2012 FY	4.3 Million EUR	32.85%
2011 FY	3.24 Million EUR	0.0%

Peer Total Debt Comparison of BioSenic S.A.

Name	Total Debt	Total Debt Difference
Boiron SA	13.7 Million EUR	-105.525%
Laboratorios Farmaceuticos Rovi, S.A.	46.63 Million EUR	39.614%
Vetoquinol SA	17.62 Million EUR	-59.752%
Valneva SE	208.81 Million EUR	86.514%
AB Science S.A.	19.1 Million EUR	-47.432%
Nanobiotix S.A.	45.48 Million EUR	38.085%
PHAXIAM Therapeutics S.A.	10.19 Million EUR	-176.115%
Vivoryon Therapeutics N.V.	38 Thousand EUR	-74007.895%
ABIVAX Société Anonyme	55.46 Million EUR	49.227%
Formycon AG	29.48 Million EUR	4.494%